(Q36893640)

16 August 2017

Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa (English)

1 reference

16 August 2017

0 references

1 reference

5

Edina Sinanovic

0 references

Helen Cox

object named as

Helen Cox

1

0 references

author name string

Lebogang Ramma

2

1 reference

16 August 2017

Lynne Wilkinson

3

1 reference

16 August 2017

Virginia Azevedo

4

1 reference

16 August 2017

15 May 2015

1 reference

Tropical Medicine and International Health

16 August 2017

1 reference

16 August 2017

20

1 reference

16 August 2017

10

1 reference

16 August 2017

1337-1345

1 reference

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Delamanid for multidrug-resistant pulmonary tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Decentralised management of drug-resistant tuberculosis (MDR- and XDR-TB) in South Africa: an alternative model of care

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4864411

Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FTMI.12544

Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FTMI.12544

21 January 2018

Identifiers

DOI

10.1111/TMI.12544

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

25975868

1 reference